Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter studyKaili Yang, Yunbo Zhao, Shikai Wu et al.|Cancer Immunology Immunotherapy|2021Cited by 30